Brief: Olix Pharmaceuticals Inc To Invest 13 Billion Won In Research And Development Centre And Headquarters Construction
25/11/2022 07:46
OliX Pharmaceuticals Inc 226950.KQ :
* OLIX PHARMACEUTICALS INC: TO INVEST 13 BILLION WON IN
RESEARCH
AND DEVELOPMENT CENTRE AND HEADQUARTERS CONSTRUCTION
Source text for Eikon: ID:
Further company coverage: 226950.KQ
Recent news on OliX Pharmaceuticals
See all newsBrief: Olix Pharmaceuticals - Olx501a Shows 29.2% Visceral Fat Reduction Versus 10.0% With Comparator In Obese Non-Human Primates
Brief: Olix Pharmaceuticals Receives Milestone Payment From L'oreal
Brief: OliX And Lilly Enter Global Licensing Agreement For Mash And Other Cardiometabolic Indications
Brief: Olix Pharmaceuticals Commences Patient Dosing In Phase 1 Clinical Trial Of Olx75016
Brief: Olix Pharmaceuticals Receives Hrec Approval To Initiate Phase 1 Clinical Trial Of Nash And Obesity Drug